AE Wealth Management LLC Sells 3,092 Shares of iShares Nasdaq Biotechnology ETF (IBB)

Share on StockTwits

AE Wealth Management LLC trimmed its stake in iShares Nasdaq Biotechnology ETF (NASDAQ:IBB) by 25.8% in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 8,873 shares of the financial services provider’s stock after selling 3,092 shares during the period. AE Wealth Management LLC’s holdings in iShares Nasdaq Biotechnology ETF were worth $856,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors also recently bought and sold shares of the stock. Towercrest Capital Management increased its holdings in iShares Nasdaq Biotechnology ETF by 43.7% in the fourth quarter. Towercrest Capital Management now owns 21,363 shares of the financial services provider’s stock valued at $2,060,000 after purchasing an additional 6,500 shares during the period. Voloridge Investment Management LLC acquired a new stake in iShares Nasdaq Biotechnology ETF in the fourth quarter valued at $5,583,000. Baker Avenue Asset Management LP increased its holdings in iShares Nasdaq Biotechnology ETF by 167.3% in the fourth quarter. Baker Avenue Asset Management LP now owns 114,767 shares of the financial services provider’s stock valued at $11,067,000 after purchasing an additional 71,837 shares during the period. Sontag Advisory LLC acquired a new stake in iShares Nasdaq Biotechnology ETF in the fourth quarter valued at $32,000. Finally, Financial Advocates Investment Management increased its holdings in iShares Nasdaq Biotechnology ETF by 36.3% in the fourth quarter. Financial Advocates Investment Management now owns 6,728 shares of the financial services provider’s stock valued at $163,000 after purchasing an additional 1,791 shares during the period. Institutional investors and hedge funds own 64.51% of the company’s stock.

Shares of IBB opened at $108.17 on Friday. iShares Nasdaq Biotechnology ETF has a 12 month low of $89.01 and a 12 month high of $122.97.

WARNING: “AE Wealth Management LLC Sells 3,092 Shares of iShares Nasdaq Biotechnology ETF (IBB)” was posted by Highlight Press and is owned by of Highlight Press. If you are reading this piece on another site, it was illegally stolen and republished in violation of international trademark & copyright legislation. The original version of this piece can be viewed at https://highlightpress.com/2019/03/23/ae-wealth-management-llc-sells-3092-shares-of-ishares-nasdaq-biotechnology-etf-ibb.html.

iShares Nasdaq Biotechnology ETF Company Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.

See Also: Reverse Stock Split

Want to see what other hedge funds are holding IBB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for iShares Nasdaq Biotechnology ETF (NASDAQ:IBB).

Institutional Ownership by Quarter for iShares Nasdaq Biotechnology ETF (NASDAQ:IBB)

Receive News & Ratings for iShares Nasdaq Biotechnology ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for iShares Nasdaq Biotechnology ETF and related companies with MarketBeat.com's FREE daily email newsletter.